Crescita Therapeutics (TSE:CTX) Stock Price Up 1.8% – Here’s What Happened

Crescita Therapeutics Inc. (TSE:CTX)’s share price traded up 1.8% during mid-day trading on Monday . The stock traded as high as C$0.58 and last traded at C$0.57. 7,000 shares traded hands during mid-day trading, a decline of 33% from the average session volume of 10,508 shares. The stock had previously closed at C$0.56.

Crescita Therapeutics Price Performance

The company has a quick ratio of 2.29, a current ratio of 2.70 and a debt-to-equity ratio of 5.77. The firm has a market capitalization of C$10.49 million, a PE ratio of -3.87 and a beta of 1.69. The firm’s fifty day simple moving average is C$0.57 and its 200-day simple moving average is C$0.59.

Insider Activity

In related news, Director Jose Darocha acquired 86,000 shares of the firm’s stock in a transaction dated Friday, December 27th. The stock was purchased at an average cost of C$0.60 per share, with a total value of C$51,436.60. 10.87% of the stock is owned by corporate insiders.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.